超媒體(00072.HK)飆逾2倍 旗下商業週刊事業群成為文心一言首批生態合作夥伴
超媒體控股(00072.HK)今日(15日)炒高,午後升勢加速一度飆2.24倍至1.2元。現報1.15元,升2.11倍,成交增至3,731萬股,涉資2,875.19萬元。
公司宣布,旗下商業週刊事業群成為百度(09888.HK)文心一言首批生態合作夥伴。後續,事業群將全面體驗並接入文心一言的智能對話技術能力。商週事業群將把百度領先的智能對話技術成果應用在商業資訊APP領域,意味著事業群中商週APP、綠金、CITYLAB、Markets、Wealth等一系列產品優先獲得領先AI技術的加持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.